Ropes & Gray represented Veradermics Inc. in its upsized initial public offering of 15,077,647 shares of its common stock at $17 per share. The company was listed on the New York Stock Exchange under the symbol "MANE." The transaction closed on Feb. 5.
Veradermics is a dermatologist-founded, late clinical-stage biopharmaceutical company focused on developing innovative therapeutics to address pervasive treatment challenges in highly prevalent aesthetic and dermatological conditions, including a non-hormonal treatment for men and women with pattern hair loss.
The team was led by capital markets partner Zach Blume and capital markets counsel Nick Roper and included health care partner Eve Brunts, executive compensation & employee benefits partner Renata Ferrari, life sciences regulatory & compliance partner Josh Oyster, IP transactions partner Melissa Rones, and tax partner Scott Pinarchick.
Stay Up To Date with Ropes & Gray
Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.
Stay in the loop with all things Ropes & Gray, and find out more about our people, culture, initiatives and everything that’s happening.
We regularly notify our clients and contacts of significant legal developments, news, webinars and teleconferences that affect their industries.